Bernard Lown
Bernard Lown was a Lithuanian-American cardiologist and inventor. Lown was the original developer of the direct current defibrillator for cardiac resuscitation, and the cardioverter for correcting rapid disordered heart rhythms. He introduced a new use for the drug lidocaine to control heartbeat disturbances.
Throughout his medical career, Lown focused on two major medical challenges: the problem of sudden cardiac death and the role of psychological stress on the cardiovascular system. His investigations led to many medical break-throughs, among them the coronary care unit. His work made possible and safe much of modern cardiac surgery, as well as a host of other innovations. In 1985, Lown accepted the Nobel Peace Prize on behalf of the International Physicians for the Prevention of Nuclear War, an organization he co-founded with Soviet cardiologist Yevgeny Chazov, who later was Minister Of Health of the USSR.
Lown was Professor of Cardiology Emeritus at the Harvard T.H. Chan School of Public Health, and Senior Physician Emeritus at the Brigham and Women’s Hospital, Boston, Massachusetts. He was the founder of the Lown Cardiovascular Center and Lown Cardiovascular Research Foundation. He also founded the Lown Institute, which aims to reform both the healthcare system and society.
Early life and education
Lown was born in Utena, Lithuania as Boruch Lac, on June 7, 1921, the son of Nison and Bela Lac. His family was Jewish, and one of his grandfathers was a rabbi. They emigrated to Maine when Lown was 14, and he attended Lewiston High School, graduating in 1938.Lown went on to study zoology at the University of Maine, obtaining a bachelor's degree from that institution in 1942. He subsequently earned an M.D. from Johns Hopkins University School of Medicine in 1945. His medical training included Yale-New Haven Hospital ; Montefiore Medical Center, Bronx, NY; and a cardiology fellowship at the Peter Bent Brigham Hospital. His mentor in cardiology was the renowned clinical cardiologist Samuel A. Levine.
Development of the defibrillator
Lown helped raise international medical awareness of sudden cardiac death as a leading cause of mortality in the developed world. Based on patient observations, Lown concluded that sudden cardiac death was reversible and survivable, and that people who were successfully resuscitated could have a near normal life expectancy.Working with his mentor Samuel A. Levine, Lown realized that the high mortality of a heart attack, then 35 percent, was most likely due to a strict regimen of bed rest. Patients remained completely recumbent for six or more weeks. A major complication of bed rest was pulmonary embolism, which accounted for a significant part of the mortality. Although Lown encountered enormous opposition and hostility among doctors to the so-called "chair treatment", in 81 patients so treated, mortality was reduced by two thirds. Once the work was published, the chair treatment was rapidly adopted and hospitalizations were reduced to several days. Untold lives were saved by getting patients out of bed.
Until the 1950s, ventricular fibrillation of the heart was treated with drug therapy alone. In 1956 American cardiologist Paul Zoll described resuscitations during open-heart surgery and, later after sudden cardiac death, by means of an alternating current electric shock, derived from a wall socket. AC current was untested as to its safety and efficacy and could cause death. In 1959, Lown demonstrated that AC was injurious to the heart and could be lethal. These investigations were conducted in the Department of Nutrition at the Harvard School of Public Health. The work was supported by Professor Frederick Stare, chairman of the Department of Nutrition.
To find a safer method of cardiac resuscitation, Lown enlisted the help of Barouh Berkovits, an electrical engineer employed by American Optical Company. In their experimental work, Lown focused on two objectives: safety and efficacy. Alternating current caused burns in skeletal and heart muscle and induced atrial as well as ventricular fibrillation in a large majority of the animal experiments.
During a year of intense experimentation, in 1961 Lown and coworkers proved that a specific direct current waveform consistently reversed ventricular fibrillation, restoring a normal heart beat without injuring heart or skeletal muscle. This became widely known as the "Lown waveform." It facilitated the worldwide acceptance of the defibrillator and cardioverter and improved survival of patients with coronary heart disease.
The DC defibrillator provided a new approach for resuscitating patients and paved the way for new possibilities in cardiac surgery. The Lown clinical group were the first to use the defibrillator and cardioverter at Peter Bent Brigham Hospital. Donald B. Effler was the first cardiac surgeon to use the DC defibrillator in 1962 at the Cleveland Clinic. According to Effler, this advance made possible modern cardiac surgery. Indeed, in 1967, Rene Favoloro performed what is regarded as the first coronary artery bypass operation in Effler’s surgical department at Cleveland Clinic. DC defibrillation provided a safe way to restore a normal heart rhythm during the surgical bypass of obstructed coronary arteries.
Lown went on to investigate the possibilities of the defibrillator to treat non-life-threatening tachycardias. He discovered that timing the electrical discharge outside the heart’s brief vulnerable period of 0.03 seconds in duration prevented ventricular fibrillation or sudden cardiac death. He called this method of timed DC discharge "Cardioversion." The cardioverter and DC defibrillator were especially valuable in coronary care units, when patients are hospitalized when most susceptible to sudden cardiac death and other potentially malignant arrhythmias.
In addition to advancing medical technology, Lown discovered new applications for two drugs that were widely used for cardiac problems: digitalis and lidocaine. Until the 1950s, digitalis poisoning was a major cause of fatality among patients with congestive heart failure. During a medical residency at the Montefiore Hospital in New York City, Lown demonstrated the critical role of potassium in determining the safe use of digitalis. His discovery led to abandonment of long acting digitalis drugs like digitoxin. Instead, the short acting digitalis glycoside gained universal acceptance. Lown also focused medical attention on potassium loss with the use of various diuretics.
In 1964, Lown introduced a new use for the drug lidocaine to control ventricular disordered heart rhythms. Lidocaine was also used in coronary units to prevent the need for resuscitation. Previously, lidocaine was used almost exclusively by dentists as an anesthetic agent.
Fiber optics
In 1957, Lown was concerned with how to visualize an atherosclerotic aortic plaque occurring in the big coronary vessels that supply nutrients to the heart muscle. It was his hope that visualizing this would lead to discovering how to treat and prevent heart attacks and sudden cardiac death. A discussion with a close friend, Elias Snitzer, a physicist at Massachusetts Institute of Technology, led to an introduction to Michael Polanyi, a physicist with American Optical Company. At the time, Polanyi was working on fiber optics. Lown received a grant from the Hartford Foundation to pursue fiber optics. However, optical technology was inadequate at the time, so this line of research was discontinued. Lown's work did show that, with fiber optics, it was possible to measure oxygen saturation in dogs, and determine the cardiac output in humans.Paradoxically, when Lown submitted two abstracts to the World Cardiology Conference in Mexico in 1964, one on the defibrillator and cardioversion, and one dealing with fiber optics, the former was rejected and the latter accepted.
Peace activism
Physicians for Social Responsibility (PSR)
In early 1961, Lown called together a group of physicians from Boston’s teaching hospitals to address the mounting threat of nuclear war between the USSR and the USA. This political subject had not been addressed previously by physicians in the United States. The new organization called itself Physicians for Social Responsibility.Among the activist participants were Jack Geiger and Victor W. Sidel. By the end of 1961, the group had drafted five research articles about the medical consequences of a ten-megaton nuclear attack on the city of Boston, a magnitude considered both possible and likely by the U.S. military. The series, "The Medical Consequences of Thermonuclear War", was published as a symposium in the New England Journal of Medicine in May 1962.
These articles encouraged anti-nuclear medical movements worldwide. Additionally, they helped pass the Limited Test Ban Treaty in the U.S. Senate.
Committee of Responsibility for War Injured Vietnamese Children (COR)
Lown was also involved in organizing COR, the Committee of Responsibility to Save War Burned and War Injured Children, of which he was a leading member. This organization aimed to bring injured and burned Vietnamese children for treatment in the United States, in order "to bring the war home."COR was headed by Herbert Needelman. It arranged for several American hospitals to treat injured Vietnamese children for free. John Constable III, from the Shriner Burn Center of the Massachusetts General Hospital in Boston, was among the first physicians to participate. He and other physicians traveled numerous times to Vietnam to choose children with injuries that could be treated.
This mission could not be accomplished without ambulance planes ferrying the very sick children. Lown led a delegation to Washington for a meeting with William F. Bundy, then Assistant Secretary of State. He was persuaded to support the objective of COR. In 1967 the Pentagon began to transport Vietnamese children to the USA.